Patents for C07K 19 - Hybrid peptides (29,428) |
---|
05/04/2005 | CN1612895A Conjugates comprising an antibody specific for the ED-B domain of fibronectin and their use for the detection and treatment of tumours |
05/04/2005 | CN1612890A Novel chimeric tnf ligands |
05/04/2005 | CN1612750A TACI-immunoglobulin fusion proteins |
05/03/2005 | US6887847 Virus derived antimicrobial peptides |
05/03/2005 | US6887670 For drug screening; solid phase synthesis; fusion proteins; genetic engineering |
05/03/2005 | US6887659 A quantitative analyzing the concentration of peptide with monoclonal antibody produced by the fused cell hybrid; medical diagnosis |
05/03/2005 | US6887472 That do not cause anaphylaxis, antigenic fusion proteins of given amino acid sequence, of a CH3 domain of an immunoglobulin (IgE) molecule; allergy vaccines; vaccine test methods in dogs |
05/03/2005 | US6887470 Covalently bonding albumin to oligopeptide; biochemical conjugation; analyzing stability |
05/03/2005 | CA2147623C Novel p-selectin ligand protein |
04/28/2005 | WO2003095971A3 Posh nucleic acids, polypeptides and related methods |
04/28/2005 | US20050091702 Expression of polypeptides in rod outer segment membranes |
04/28/2005 | US20050090461 Synthesizing polyketide fusion protein comprising acyltransferase domain for use as anthelminthic, insecticide, antitumor, immunosuppressant, fungicidal and/or bactericidal agents |
04/28/2005 | US20050089970 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
04/28/2005 | US20050089957 Chimera; immunoglobuins; antibodies; host cells; immunohistochemistry |
04/28/2005 | US20050089933 Compositions and methods for surrogate antibody modulation of an immune response and transport |
04/28/2005 | US20050089841 Induction of a Th1-like response in vitro |
04/28/2005 | CA2543406A1 Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption |
04/28/2005 | CA2536082A1 Therapeutic uses of chemokine variants |
04/27/2005 | EP1526183A2 Dimer of a peptide derived from the C-terminal sequence of human superoxide dismutase facilitating the penetration of a substance into cells and/or cell nuclei |
04/27/2005 | EP1526141A2 MHC complexes and uses thereof |
04/27/2005 | EP1524994A1 Vaccine compositions containing amyloid beta1-6 antigen arrays |
04/27/2005 | EP1423527A4 System for detecting protease |
04/27/2005 | EP1150707B1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS |
04/27/2005 | EP0939818B1 Recombinant toxin fragments |
04/27/2005 | CN1610737A Phenotypic screen of chimeric proteins |
04/27/2005 | CN1610695A Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
04/27/2005 | CN1610556A Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
04/27/2005 | CN1609222A Alkaline phosphatase gene and its coding protein and application |
04/27/2005 | CN1609124A Calreticulin-tumor necrosis factor correlated apoptosis inducing ligand fusion protein and its prepn and use |
04/27/2005 | CN1198936C Alzheimer's disease secretase |
04/26/2005 | US6884620 Genetic engineering |
04/26/2005 | US6884618 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
04/26/2005 | US6884574 Methods of identifying agents which inhibit GPR-9-6 |
04/26/2005 | US6884431 Method for treating proliferative diseases with p27 and fusions thereof |
04/26/2005 | CA2253871C Ret ligand (retl) for stimulating neural and renal growth |
04/21/2005 | WO2005035585A1 Support having affinity for antibody |
04/21/2005 | CA2542860A1 Fluorescence indicator utilizing fret |
04/21/2005 | CA2542046A1 Fused protein composition |
04/20/2005 | EP1523558A1 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
04/20/2005 | EP1523336A1 Targeted agents for nerve regeneration |
04/20/2005 | EP0871704B1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor |
04/20/2005 | EP0759995B1 Fusion glycoprotein from hcmv and hsv |
04/20/2005 | CN1608129A Alkaline protease from bacillus sp. (DSM 14392) and washing and cleaning products comprising said alkaline protease |
04/20/2005 | CN1197877C AsLc-IFN fusion protein and its preparation |
04/20/2005 | CN1197876C Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production |
04/19/2005 | US6881832 Comprises nucleotide sequences coding signal sequences for transport of heterologous proteins into preferential cellular compartments |
04/19/2005 | US6881821 Hepatitis-C virus type 4, 5, and 6 |
04/19/2005 | US6881577 DNA-peptide-lipid complex for enhancing gene transfer into cells; cationic liposomes |
04/19/2005 | US6881564 Enzymatic peptide comprising modified asparaginic residues for treatment of tumors, infection, liver and autoimmune disorders |
04/14/2005 | WO2005033147A1 Interacting polypeptide comprising a heptapeptide pattern and a cellular penetration domain |
04/14/2005 | WO2005032496A2 Hydrolases, nucleic acids encoding them and mehods for making and using them |
04/14/2005 | WO2005002512A3 Immunotherapeutic vaccine strategy |
04/14/2005 | WO2004096989A3 Single chain antigen-binding polypeptides for polymer conjugation |
04/14/2005 | WO2004092215A3 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
04/14/2005 | WO2004031105A3 Use of a33 antigens and jam-it |
04/14/2005 | US20050080237 Oligomeric molecules and uses thereof |
04/14/2005 | US20050080233 Expression vector comprising nucleotide sequences coding bacterial outer membrane protein for use in diagnosis, prevention and treatment of microorganismal infection |
04/14/2005 | US20050080014 Thrombopoietic compounds |
04/14/2005 | US20050079541 Immunoadhesin comprising a glycorprotein v1 domain |
04/14/2005 | US20050079538 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; anticarcinogenic agents |
04/14/2005 | CA2541015A1 Igf binding proteins |
04/14/2005 | CA2540520A1 Interacting polypeptide comprising a heptapeptide pattern and a cellular penetration domain |
04/14/2005 | CA2524209A1 Antiviral agents for the treatment, control and prevention of infections by coronaviruses |
04/14/2005 | CA2515583A1 Hydrolases, nucleic acids encoding them and methods for making and using them |
04/13/2005 | EP1522591A2 Transgenically produced non-secreted proteins |
04/13/2005 | EP1521968A1 Secreted polypeptide species associated with cardiovascular disorders |
04/13/2005 | EP1521824A2 Nucleic acid-associated proteins |
04/13/2005 | EP1521775A1 Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer |
04/13/2005 | EP1478747A4 Method for making purified plasminogen activator-inhibitor type 1 (pai-1) and purified pai-1 made therefrom |
04/13/2005 | EP1465912A4 Novel chimeric tnf ligands |
04/13/2005 | EP1356075A4 Protein scaffolds for antibody mimics and other binding proteins |
04/13/2005 | EP1183353B1 Modified chimeric polypeptides with improved pharmacokinetic properties |
04/13/2005 | CN1606626A Novel alkaline protease from bacillius sp. (DSM 14390) and washing and cleaning products comprising said novel alkaline protease |
04/13/2005 | CN1606619A Novel alkaline protease from bacillus gibsonii (DSM 14391) and washing and cleaning agents containing said novel alkaline protease |
04/13/2005 | CN1606618A Novel alkali protease formed by bacillus gibsonii (DSM 14393) and washing and cleaning agents containing said novel alkali protease |
04/13/2005 | CN1606570A A fusion protein suitable to highly effective expression and production method thereof |
04/13/2005 | CN1606453A Cripto blocking antibodies and uses thereof |
04/13/2005 | CN1196791C Psudomonas exotoxin-myelin basic protein chimeric proteins |
04/13/2005 | CN1196788C Assembly of wild-type and chimeric influenza virus-like particles (VLPS) |
04/13/2005 | CN1196785C Beta-amyloid peptdie-binding proteins and polynucleotides encoding the same |
04/13/2005 | CN1196495C Mutant human CD80 and compositions and methods of making and using the same |
04/12/2005 | US6878376 Modulate immunology response |
04/12/2005 | CA2417135C Chimeric pre-activated transcription factors |
04/12/2005 | CA2123363C Lysosomal enzyme-cleavable antitumor drug conjugates |
04/12/2005 | CA2113813C Immunoglobulin variants for specific fc epsilon receptors |
04/12/2005 | CA2074825C Chimeric chains for receptor-associated signal transduction pathways |
04/07/2005 | WO2002066615A3 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
04/07/2005 | US20050076395 Transgenic mouse comprising nucleotide sequences coding immunoglobulin domains j, c, v and d for use as bioreactor in biosynthesis of human antibodies; immunodiagnostics |
04/07/2005 | US20050074839 Novel survivin interacting protein tpr1 |
04/07/2005 | US20050074797 FHIT proteins and nucleic acids and methods based thereon |
04/07/2005 | US20050074427 IL-17 like molecules and uses thereof |
04/07/2005 | US20050074426 A conjugate of a cytokine and a tumor targeting moiety with numerous provisos |
04/06/2005 | EP1520019A2 Adapter-directed display system |
04/06/2005 | EP1519950A2 Components of the presenilin-complex |
04/06/2005 | EP1284997B1 Therapeutic compounds for ovarian cancer |
04/06/2005 | EP1117769B1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
04/06/2005 | EP1002093B1 Preparation and use of recombinant influenza a virus m2 constructs and vaccines |
04/06/2005 | EP0553244B2 Targeted immunostimulation with bispecific reagents |
04/06/2005 | CN1604966A Direct targeting binding proteins |
04/06/2005 | CN1604965A 生长激素融合蛋白 Growth hormone fusion protein |